About Starkey Laboratories India Private Limited
Data last updated: 24 February 2026
Starkey Laboratories India Private Limited is a foreign private limited company based in New Delhi, Delhi, India, a subsidiary of Starkey Laboratories Inc.. It specialises in consumer and professional services, a part of the broader travel and hospitality sector. Incorporated on 13 February 2007, the company has been in operation for over 19 years.
Registered with ROC Delhi under CIN U73200KA2007FTC041768.
Capital: an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Akhil Chauhan and Sayali Nikhil Deshkar.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 401 Third Floor Vardhman Plaza Vasundhara Enclave, New Delhi, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹76.6 Cr, a growth of 7% compared to the previous year.
The company has a workforce of approximately 107 employees as per the latest available data. It operates as a subsidiary of Starkey Laboratories Inc..
The company is associated with 1 brand - Starkey.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website starkeyindia.com.
-
Email**************
-
Telephone**************
-
Website**************
-
Social Media
-
Registered Address401 Third Floor Vardhman Plaza Vasundhara Enclave, New Delhi, Delhi, India – 110096
-
IndustryTravel and Hospitality, Consumer Professional Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Starkey Laboratories India Private Limited
Starkey Laboratories India Private Limited has one previous CIN (Corporate Identification Number): U73200KA2007FTC041768. The current CIN is U73200DL2007FTC227985, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U73200DL2007FTC227985 | Current |
| U73200KA2007FTC041768 | Previous |
Associated Brands with Starkey Laboratories India Private Limited
Starkey Laboratories India Private Limited operates one associated brand: Starkey. These brands represent Starkey Laboratories India Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Developer and manufacturer of hearing aids | starkey.com |
Competitors & Alternatives of Starkey Laboratories India Private Limited
Brands and companies operating in the same space as Starkey Laboratories India Private Limited include Eargo, Audicus, Amplifon and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Eargo
|
Hearing aids are supplied for individuals with hearing disabilities. | San Jose, United States, United States | 2010 |
Audicus
|
Hearing aids are manufactured and sold online at reduced prices. | Hoboken, United States, United States | 2011 |
Amplifon
|
Hearing aids and accessories are manufactured, distributed, and retailed. | Milan, Italy, Italy | 1949 |
Eversound
|
Wireless headphone systems for seniors with hearing loss are provided. | Boston, United States, United States | 2015 |
IntriCon
|
Miniature hearing aids and biomedical solutions are developed by IntriCon. | Arden Hills, United States, United States | 1977 |
Sonic
|
Hearing aids and related audio equipment are manufactured. | Somerset, United States, United States | 1996 |
InSound Medical
|
Extended-wear, invisible in-ear hearing systems were developed and marketed. | Newark, United States, United States | 2003 |
Earlens Corporation
|
Light-driven hearing aids are developed for individuals with hearing loss. | Menlo Park, United States, United States | 2005 |
Business Activity of Starkey Laboratories India Private Limited
Starkey Laboratories India Private Limited is engaged in multiple principal business activities such as manufacturing, trade, and information and communication, with detailed activities including other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities, wholesale trading, computer programming, consultancy and related activities. The company has 3 registered principal business activity segments, demonstrating its operational diversity and market reach.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | ********* |
| G | Trade | G1 | Wholesale Trading | ********* |
| J | Information and communication | J6 | Computer programming, consultancy and related activities | ********* |
Board of Directors of Starkey Laboratories India Private Limited
Starkey Laboratories India Private Limited is currently managed by 4 directors, with 11 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Akhil Chauhan | Managing Director | 30 Aug 2022 | 3 Years 10 Months | Current |
| Sayali Nikhil Deshkar | Director | 20 Sep 2021 | 4 Years 9 Months | Current |
| William Franklin Austin | Director | 30 Jun 2017 | 9 Years 0 Months | Current |
| Brandon Lee Sawalich | Director | 30 Jun 2017 | 9 Years 0 Months | Current |
Financials of Starkey Laboratories India Private Limited FY 2025 filings available
Starkey Laboratories India Private Limited reported revenue of ₹76.6 Cr (up 7% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Charges & Borrowings Starkey Laboratories India Private Limited
Starkey Laboratories India Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Starkey Laboratories India Private Limited
View historical data on people associated with Starkey Laboratories India Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Starkey Laboratories India Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Starkey Laboratories India Private Limited
GSTIN & GST Filing Data of Starkey Laboratories India Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Starkey Laboratories India Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Starkey Laboratories India Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Starkey Laboratories India Private Limited
MSME Payment Delays by Starkey Laboratories India Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Starkey Laboratories India Private Limited
Subsidiaries & Group Companies of Starkey Laboratories India Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Starkey Laboratories India Private Limited with ownership details.
MCA Filings & Documents of Starkey Laboratories India Private Limited
MCA Filings & Documents of Starkey Laboratories India Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Starkey Laboratories India Private Limited
Frequently Asked Questions about Starkey Laboratories India Private Limited
Starkey Laboratories India Private Limited is an active foreign private limited company in the travel and hospitality sector based in New Delhi, Delhi, India. It was incorporated on 13 February 2007 (19+ years old) and is registered under CIN U73200DL2007FTC227985. The company has 107 employees.
Starkey Laboratories India Private Limited reported revenue of ₹76.6 Cr for FY 2025 (up 7.00% YoY).
The current directors of Starkey Laboratories India Private Limited are:
The primary industry of Starkey Laboratories India Private Limited is travel and hospitality. The company specifically operates in consumer professional services. The company is currently active in this sector.
Starkey Laboratories India Private Limited can be reached at the registered office: 401 Third Floor Vardhman Plaza Vasundhara Enclave, New Delhi, Delhi, India – 110096, or through the website starkeyindia.com.
The authorised capital is ₹5 Lakh, and the paid-up capital is ₹5 Lakh.